Philipp Müller about Nicotine Vaccines

Philipp Müller is  Executive Vice President Clinical Development of Cytos Biotechnology. He talks about  nicotine vaccines. LISTEN

Philipp Müller, MD, has been Executive Vice President Clinical Development of Cytos Biotechnology since March 2003. He received his MD from the University of Basel and also holds a Clinical Pharmacologist SKP degree of the Swiss Society for Clinical Pharmacology.

He joined Cytos Biotechnology from Novartis Pharma AG, where he was Global Head of Clinical Pharmacology Scientists and Deputy of Global Head Clinical Pharmacology. He brings more than 20 years of experience in human pharmacology and clinical research to Cytos Biotechnology.

Comments

[Swedsnus]

I think Anti nocotine might be very useful to quit smoking. Many people are trying to different measures including Swedish snus to quit smoking cigarette but 50-70% are failing.

[Amyobus Key]

Don't mess with introducing any more chemicals into the body. Smoking introduces nicotine that upsets the acid-alkali balance, by interfering with the body's natural ability to balance itself. When the smoker learns that he has interfered with the balance by smoking, he can accept that ceasing to smoke for a brief period 7 - 14 days will put him back on track to re-establishing his natural balance. You crave alkaline because you gave your body nicotine after eating and other acid-producing events. When you deny your body for a brief period, it will restore its own balance. Don't introduce another chemical into the equation because your commercial interests are looking for another reason to make a buck on someone's grief.